| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.2 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.058 | 0.2 |